An evaluation of liver function abnormality in phase 1 clinical test.Especially on the study in placebo continual medication group.
スポンサーリンク
概要
著者
関連論文
- 食道へ穿孔した胸部大動脈瘤の1例
- 内科的治療により食道静脈瘤並びにHBVマーカーが消失したキャリア発症肝硬変症の1例
- 肝疾患における尿中neopterin測定の意義(第1報)
- B-15 薬学生の外来診療見学実習に関する検討
- MCI-186(Edaravone)の第1相臨床試験 : 単回および反復投与試験における安全性と薬物動態の検討
- Phase I Study実施上の諸問題(新薬の臨床試験の実施をめぐって)
- 脾過誤腫の1手術例
- ルポイド肝炎をoverlapしたAMA陰性原発性胆汁性肝硬変
- Metabolism of ketoprofen following single rectal dosage in elderly subjects.
- The effect on the activity of Na, K-ATPase in liver homogenate or liver plasma membrane during administration of dibutyryl cyclic AMP.
- Nutritional management of an examinee in the clinic phase I study.The effect on liver function test under overnourishment.
- An evaluation of liver function abnormality in phase 1 clinical test.Especially on the study in placebo continual medication group.
- Effects of Ethanol on Metabolism of Benzodiazepine Hypnotics.
- Evaluation of the anti Hepatitis C antibody tests in the mass medical examination
- Blood level of benzodiazepine when a benzodiazepine sleeping pill and ethanol are taken together.
- A case of multiple focal nodular hyperplasia in the liver.
- Research on metabolism of Oxsoralen.
- Studies on the choice of subjects in clinical phase I tests. With emphasison evaluation of tranaminase levels prior to testing. 2.
- Studies on choice of subjects in clinical phase I study. Especially on evaluation of transaminase level tested before the study.